Fungal infections in pediatric patients: challenges and considerations in treatment

There is and will be further needed therapeutic drug monitoring for all antifungal drugs in children. Prioritizing pediatric-specific research and developing standardized treatment protocols are crucial. Furthermore, regulatory reforms are essential to expedite access to new diagnostic and treatment strategies for IFD in children.